Results 41 to 50 of about 14,940,180 (291)

Epidemiology of Hepatitis D Virus and Associated Factors in Patients Referred to Level Three Hepatitis Clinic, Fars Province, Southern Iran [PDF]

Iranian Journal of Medical Sciences
Background: Hepatitis D is caused by the hepatitis D virus (HDV) and affects those who have already been infected with the hepatitis B virus (HBV). The epidemiology of hepatitis D in Fars Province, Iran, is poorly understood.
Ali Reza Safarpour, Alireza Shahedi, Mohammad Reza Fattahi, Erfan Sadeghi, Majid Akbarzadeh, Lida Ahmadi, Nika Nikmanesh, Ebrahim Fallahzadeh Abarghooee, Seyedeh Azra Shamsdin, Hassan Akrami, Yousef Nikmanesh   +10 more
doaj   +1 more source

VITAMIN D LEVELS IN PATIENTS WITH CHRONIC HEPATITIS B, CHRONIC HEPATITIS C, AND HEALTH CONTROLS [PDF]

Journal of IMAB, 2019
Purpose: Hepatitis B virus and Hepatitis C virus infection are the most common cause of acute and chronic hepatitis. Over the past decade, numerous studies reported that patients with chronic liver disease, especially HCV-positive and HBV-positive ...
Biljana Ilkovska, Bisera K. Trifunova, Sandra Hristovska, Marina Ivanovska   +3 more
doaj   +1 more source

Comparative analysis of vitamin D contents in patients with chronic viral hepatitis C and healthy.

Medičnì Perspektivi, 2020
From scientific literature it is known that vitamin D helps maintain the most important functions of the immune system, there is evidence of its role in inflammatory and metabolic diseases of the liver, including infection with hepatitis C.
L. L. Shostakovych-Koretskaya, M. A. Nikolaychuk, I. V. Budayeva, O. P. Shevchenko-Makarenko, K. Yu. Lytviy, S. V. Biletska   +5 more
doaj   +3 more sources

Rapid suppression of HBV replication before related liver transplantation in a patient with HDV superinfection. Clinical case report

Вестник трансплантологии и искусственных органов
Chronic hepatitis B virus (HBV) infection is one of the main problems of modern transplantology and transplant hepatology, often leading to potentially fatal complications. The only definitive treatment for HBV-related cirrhosis is liver transplantation.
U. R. Salimov, P. Balachandran, D. B. Tulyaganov, M. R. Ruzibakieva, F. A. Khadjibaev, K. E. Anvarov   +5 more
doaj   +1 more source

Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium

, 1999
Hepatitis C is a global health problem caused by infection with the hepatitis C virus. Although representative prevalence data are not available from many countries, available data indicate that approximately 3% of the world's population is infected with
A.R. ZANETTI, WHO TECHNICAL CONSULTATION ON HEPATITIS C   +1 more
core   +1 more source

Structure‐forward targeting of claudins with synthetic binders

FEBS Letters, EarlyView.
Claudins form the paracellular barriers between epithelial and endothelial tissues at tight junctions and are targets for molecular binders with the goal of modulating barrier permeability. Claudin‐binding molecules are relevant in drug delivery or in altering claudin interactions with disease‐causing proteins.
Alex J. Vecchio
wiley   +1 more source

Family foci of HDV infection in the Republic of Sakha (Yakutia)

Журнал инфектологии
This study is devoted to the analysis of the epidemiological situation of chronic hepatitis D in Yakutia, as a region where chronic viral hepatitis is widespread.Aim: To characterize family foci of chronic hepatitis D in the Republic of Sakha (Yakutia ...
O. M. Zamorshchikova, S. S. Sleptsova, S. S. Sleptsov   +2 more
doaj   +1 more source

Engineering peptides into antibodies—opportunities and strategies for therapeutic innovation

FEBS Letters, EarlyView.
Peptides and antibodies occupy complementary therapeutic niches. Peptides recognize difficult targets in a compact format, while antibodies add specificity, long half‐life, and effector functions. This review examines strategies that merge both modalities—peptide grafting into loops, terminal and Fc fusions, and bioconjugation—highlighting how ...
Jinling Wang, Ruslana Romaniuk, Hristo L. Svilenov   +2 more
wiley   +1 more source

Liver organoids: modelling complexity in homeostasis and disease

FEBS Letters, EarlyView.
Studying liver in vitro has been challenging because simple 2D cell cultures fail to capture liver's cellular and architectural complexity. To bridge this gap, scientists increasingly use organoids, 3D liver models which better mimic liver composition and function. This review examines recent advances in liver organoid complexity and realism, discusses
Anna M. Dowbaj, Meritxell Huch
wiley   +1 more source

Clinical Features of Hepatitis

, 2005
This chapter contains sections titled: General features Hepatitis A Hepatitis B Hepatitis C Hepatitis D (delta) Hepatitis
Schiff, Eugene R, Regev, Arie, Eugene R Schiff, Arie Regev   +3 more
core   +1 more source